Contact : Mr.Thyen
Email us at firstname.lastname@example.org
Whatsapp : +86 180 3817 6818
Product Name: MK-2866, Ostarine
Dosages and Suggestion
Recommended maximum dose OSTARINE about 25 mg once a day for men, females and 12.5 mg. It has a half-life of 24 hours a day.
Improve the minimum recommended dose aesthetic constitution (means) male is 12.5 mg. Low dose may produce little results notification clause or muscle growth, but it will help to health. Women's minimum recommended dose, and for those who seek to improve health, 5 mg per day, it should be noted that therapeutic doses as low as 3 mg a day have been reported in the gender is good.
Ostarine, also known as MK-2866, is in class of drugs called SARMS, which stands for selective androgen receptor modulators.
Ostarine is selective in that it binds only to bone and muscle androgen receptors, which prevents things like prostate issues or hair loss or any of the other nasty side effects anabolic steroids can result in.
1.Enobosarm (Ostarine, MK-2866, GTx-024) - affects both muscle and bone, intended mainly for osteoporosis but also general treatment for andropause and reversing muscle sarcopenia in the elderly and for cachexia in cancer patients
2.Nonsteroidal selective androgen receptor modulator (SARM) used in the treatment of osteoporosis and muscle wasting in animal models. A potential compound for the treatment of hypoactive sexual desire disorder.
Applications of SARM mk-2866/ostarine:
Selective androgen receptor modulators may be used by athletes to assist in training and increase physical stamina and fitness, potentially producing effects similar to anabolic steroids.
Ostarine is a potent and tissue-selective androgen receptor modulator (SARM) for treatment of conditions such as muscle wasting and osteoporosis. These patent products for research purposes only use. Ostarine (GTx-024, MK-2866, Enobosarm, S-22) is an orally bioavailable nonsteroidal selective androgen receptor modulator. Therefore, ostarine can be used for treatment of conditions such as muscle wasting and osteoporosis.
An odorless, almost white or white powder
The retention time of the major peak is
Loss on Drying
Not more than 0.5%
Not less than 99.0%
Not more than 0.1%
Not more than 20 ppm
SARMs Powder List
1202044-20-9 / 841205-47-8